Insider Shareholders with Direct Ownership of Pliant Therapeutics, Inc. (PLRX)
This section provides a comprehensive overview of the insiders with direct ownership of Pliant Therapeutics, Inc. (PLRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
PLIANT THERAPEUTICS, INC. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Third Rock Ventures Iii, L.P.
> 10% Shareholder |
5,559,440 | 4,000,000 | 1,839,160 $25.9 Million | 3 |
Nov 29, 2022
Reduced 52.09%
|
Bernard Coulie
President and CEO |
871,075 | 444,132 | 482,936 $6.79 Million | 45 |
Jul 10, 2024
Reduced 7.42%
|
Keith Lamont Cummings
Chief Financial Officer |
362,847 | 108,800 | 282,115 $3.97 Million | 22 |
Jul 10, 2024
Reduced 3.72%
|
Hans Hull
Chief Business Officer |
195,540 | 88,526 | 227,494 $3.2 Million | 17 |
Jul 10, 2024
Reduced 4.17%
|
Eric Lefebvre
Chief Medical Officer |
211,463 | 180,067 | 213,052 $3 Million | 17 |
Jul 10, 2024
Reduced 5.47%
|
Mike Ouimette
General Counsel & Corp. Sec'y |
159,828 | 65,784 | 94,044 $1.32 Million | 16 |
Jul 10, 2024
Reduced 7.53%
|
Lily Cheung
Chief Human Resource Officer |
26,000 | 0 | 26,795 $377,005 | 1 |
Jan 23, 2024
Added 49.25%
|